결과 페이지 2 - 업종: 의약품 제조업체 - 일반 주식 시장 - 시세 및 가격
가격, 시가 총액, PE 및 EPS가 포함된 모든 주식 목록
모든 나라들
모든 거래소
- {{item.name}}
- 모든 거래소
- ASX (1)
- BSE (10)
- Budapest (1)
- Buenos Aires (13)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (45)
- Helsinki (2)
- HKSE (2)
- IOB (17)
- Istanbul (1)
- KSE (3)
- LSE (3)
- MCE (1)
- Mexico (14)
- Milan (5)
- Munich (1)
- NasdaqCM (1)
- NasdaqGM (1)
- NasdaqGS (6)
- NSE (10)
- NYSE (8)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (5)
- Paris (3)
- Santiago (4)
- São Paulo (14)
- SES (1)
- Shanghai (6)
- Shenzhen (6)
- Stockholm (3)
- Swiss (6)
- Taipei Exchange (1)
- Tokyo (9)
- Vienna (13)
- XETRA (12)
모든 업종
- {{item.name}}
- 모든 업종
- 보건의료 (265)
의약품 제조업체 - 일반 (265)
- {{item.name}}
- 모든 산업
- 농업 입력 (323)
- 건축 재료 (471)
- 화학약품 (596)
- 특수 화학약품 (1365)
- 목재 및 재목 생산 (160)
- 종이 및 종이 제품 (269)
- 알루미늄 (142)
- 구리 (217)
- 기타 산업용 금속 및 채광 (2762)
- 금 (1700)
- 은 (83)
- 기타 귀금속 및 채광 (664)
- 점결탄 (72)
- 강철 (743)
- 자동차 및 트럭 대리점 (212)
- 자동차 제조업체 (390)
- 자동차 부품 (1160)
- 레저 차량 (84)
- 가구, 비품 및 가전제품 (509)
- 주거용 건축 (214)
- 섬유 제조 (521)
- 의류 제조 (443)
- 신발 및 액세서리 (206)
- 포장 및 용기 (482)
- 개인 서비스 (140)
- 식당 (538)
- 의류 소매 (289)
- 백화점 (276)
- 주택 개조 소매 (106)
- 명품 (260)
- 인터넷 소매 (407)
- 전문 소매 (547)
- 도박 (205)
- 레저 (410)
- 숙박 (323)
- 리조트 및 카지노 (188)
- 여행 서비스 (193)
- 자산 관리 (1966)
- 은행 - 종합 (289)
- 은행 - 지역 (2200)
- 모기지 금융 (171)
- 자본 시장 (887)
- 금융 데이터 및 증권 거래소 (152)
- 보험 - 생명 (247)
- 보험 - 재산 및 상해 (266)
- 보험 - 재보험 (72)
- 보험 - 특수 (72)
- 보험 중개인 (67)
- 보험 - 종합 (305)
- 쉘 회사 (1821)
- 금융 대기업 (102)
- 신용 서비스 (663)
- 부동산 - 개발 (876)
- 부동산 서비스 (1138)
- 부동산 - 종합 (304)
- REIT - 의료 시설 (63)
- REIT - 호텔 및 모텔 (84)
- REIT - 산업 (140)
- REIT - 사무 (168)
- REIT - 주거 (106)
- REIT - 소매 (229)
- REIT - 모기지 (129)
- REIT - 특수 (83)
- REIT - 종합 (328)
- 음료 - 양조업체 (154)
- 음료 - 와인 및 증류주 (234)
- 음료 - 비알코올 (213)
- 제과업체 (170)
- 농산물 (608)
- 가정용품 및 개인용품 (523)
- 포장 식품 (1269)
- 교육 및 훈련 서비스 (306)
- 할인점 (96)
- 식품 유통 (209)
- 식료품점 (233)
- 담배 (105)
- 생명공학 (2608)
- 의약품 제조업체 - 일반 (265)
- 의약품 제조업체 - 특수 및 제네릭 (1632)
- 의료 플랜 (57)
- 요양 시설 (554)
- 의약품 소매업체 (155)
- 건강 정보 서비스 (419)
- 의료 기기 (916)
- 의료 기기 및 소모품 (501)
- 진단 및 연구 (429)
- 의료 유통 (138)
- 유틸리티 - 독립 전력 생산자 (150)
- 유틸리티 - 재생 에너지 (531)
- 유틸리티 - 규제 수원 (166)
- 유틸리티 - 규제 전기 (437)
- 유틸리티 - 규제 가스 (197)
- 유틸리티 - 종합 (202)
- 통신 서비스 (912)
- 광고 대행사 (514)
- 출판 (259)
- 방송 (214)
- 엔터테인먼트 (683)
- 인터넷 콘텐츠 및 정보 (527)
- 전자 게임 및 멀티미디어 (485)
- 석유 및 가스 시추 (80)
- 석유 및 가스 E&P (1187)
- 석유 및 가스 통합 (246)
- 석유 및 가스 미드스트림 (232)
- 석유 및 가스 정제 및 마케팅 (277)
- 석유 및 가스 장비 및 서비스 (480)
- 열 석탄 (228)
- 우라늄 (140)
- 항공우주 및 방위 (566)
- 전문 비즈니스 서비스 (638)
- 컨설팅 서비스 (195)
- 렌탈 및 임대 서비스 (222)
- 보안 및 보호 서비스 (266)
- 채용 및 고용 서비스 (252)
- 대기업 (730)
- 엔지니어링 및 건설 (1494)
- 인프라 운영 (156)
- 건축 제품 및 장비 (510)
- 농기계 및 중장비 (377)
- 산업 유통 (234)
- 비즈니스 장비 및 소모품 (141)
- 특수 산업 기계 (1714)
- 금속 제작 (393)
- 오염 및 처리 제어 (265)
- 도구 및 액세서리 (240)
- 전기 장비 및 부품 (895)
- 공항 및 항공 서비스 (134)
- 항공사 (230)
- 철도 (261)
- 해상 운송 (503)
- 트럭 운송 (99)
- 통합 화물 및 물류 (389)
- 폐기물 관리 (355)
- IT 서비스 (1181)
- 소프트웨어 - 애플리케이션 (2025)
- 소프트웨어 - 인프라 (928)
- 통신 장비 (732)
- 컴퓨터 하드웨어 (431)
- 가전 제품 (279)
- 전자 부품 (973)
- 전자 및 컴퓨터 유통 (242)
- 과학 기기 및 기술 도구 (347)
- 반도체 장비 및 재료 (349)
- 반도체 (608)
- 태양광 (224)
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 |
|---|
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | |
|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} | |
| Johnson & Johnson JNJ.MX | $2,882.18 170.66 USD |
+0.64
|
$6.93T 410.62B USD | $15 0.89 USD | $2,882.18 170.66 USD | $2,882.18 170.66 USD | $6.93T 410.62B USD | 16.83 | $171.25 10.14 USD | |
| Johnson & Johnson JNJB34.SA | $55.2 11.19 USD |
-0.9
|
$1.99T 403.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.99T 403.79B USD | 16.77 | $3.29 0.67 USD | |
| Johnson & Johnson JNJ.SN | $148.27 — |
0
|
$396.76B — | $0 — | $145.55 — | $145.55 — | $396.76B — | 22.43 | $6.61 — | |
| AbbVie Inc. ABBV34.SA | $65.45 13.27 USD |
+2.91
|
$1.85T 375.01B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.85T 375.01B USD | 81.81 | $0.8 0.16 USD | |
| AbbVie Inc. ABBV.MX | $3,547 210.03 USD |
0
|
$6.27T 370.99B USD | $4 0.24 USD | $3,547 210.03 USD | $3,547 210.03 USD | $6.27T 370.99B USD | 79.36 | $44.69 2.65 USD | |
| Johnson & Johnson JNJ.F | $130.6 142.76 USD |
+0.6
|
$314.99B 344.32B USD | $1.36K 1.49K USD | $129.66 141.74 USD | $130.78 142.96 USD | $314.99B 344.32B USD | 16.70 | $7.82 8.55 USD | |
| Johnson & Johnson JNJ.VI | $130.32 142.46 USD |
+0.25
|
$313.56B 342.76B USD | $0 0 USD | $130.16 142.28 USD | $131.12 143.33 USD | $313.56B 342.76B USD | 16.68 | $7.81 8.54 USD | |
| AstraZeneca PLC AZN.BA | $41,875 49.5 USD |
+5.81
|
$267.49T 316.18B USD | $235 0.28 USD | $41,000 48.46 USD | $41,950 49.59 USD | $267.49T 316.18B USD | 7.37 | $5.68K 6.71 USD | |
| AbbVie Inc. ABBV.VI | $159.2 174.03 USD |
-1.24
|
$284.36B 310.84B USD | $0 0 USD | $161 175.99 USD | $161.8 176.87 USD | $284.36B 310.84B USD | 78.03 | $2.04 2.23 USD | |
| Novartis AG NVS.BA | $34,875 41.22 USD |
-1.76
|
$262.58T 310.37B USD | $126 0.15 USD | $34,075 40.28 USD | $34,875 41.22 USD | $262.58T 310.37B USD | 2.39 | $14.58K 17.23 USD | |
| AbbVie Inc. 4AB.F | $160 174.9 USD |
-0.62
|
$282.62B 308.95B USD | $37 40.45 USD | $160 174.9 USD | $161.4 176.43 USD | $282.62B 308.95B USD | 78.81 | $2.03 2.22 USD | |
| AbbVie Inc. 4AB.DE | $159.2 174.03 USD |
-1.24
|
$281.21B 307.4B USD | $628 686.49 USD | $160.2 175.12 USD | $161.8 176.87 USD | $281.21B 307.4B USD | 78.42 | $2.03 2.22 USD | |
| Roche Holding AG ROGN.MX | $6,365.83 376.94 USD |
0
|
$4.85T 287.16B USD | $0 0 USD | $6,365.83 376.94 USD | $6,365.83 376.94 USD | $4.85T 287.16B USD | 26.45 | $240.63 14.25 USD | |
| Merck & Co., Inc. MRK.PA | $101.4 110.84 USD |
0
|
$260.61B 284.88B USD | $250 273.28 USD | $100.2 109.53 USD | $101.6 111.06 USD | $260.61B 284.88B USD | 21.03 | $4.82 5.27 USD | |
| Merck & Co., Inc. MRK.BA | $19,000 22.46 USD |
-0.52
|
$229.97T 271.83B USD | $6.19K 7.32 USD | $18,550 21.93 USD | $19,100 22.58 USD | $229.97T 271.83B USD | 0.24 | $78.59K 92.89 USD | |
| Roche Holding AG RHHBF | $340.41 — |
0
|
$260.84B — | $61 — | $346.01 — | $346.01 — | $260.84B — | 27.01 | $12.6 — | |
| AstraZeneca PLC AZNN.MX | $1,417 83.9 USD |
0
|
$4.39T 260.14B USD | $4.64K 274.8 USD | $1,417 83.9 USD | $1,417 83.9 USD | $4.39T 260.14B USD | 29.93 | $47.33 2.8 USD | |
| Novartis AG NVSN.MX | $2,092.19 123.88 USD |
0
|
$4.37T 258.76B USD | $0 0 USD | $2,092.19 123.88 USD | $2,092.19 123.88 USD | $4.37T 258.76B USD | 17.21 | $121.56 7.2 USD | |
| Novartis AG N1VS34.SA | $63.45 12.86 USD |
0
|
$1.26T 255.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.26T 255.54B USD | 18.12 | $3.5 0.71 USD | |
| AstraZeneca PLC A1ZN34.SA | $64.89 13.15 USD |
+0.98
|
$1.21T 244.66B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.21T 244.66B USD | 28.58 | $2.27 0.46 USD | |
| Roche Holding AG RHO6.F | $34.82 38.06 USD |
+0.62
|
$222.66B 243.4B USD | $500 546.57 USD | $34.16 37.34 USD | $34.82 38.06 USD | $222.66B 243.4B USD | 25.41 | $1.37 1.5 USD | |
| Pfizer Inc. PFE.ST | $422.6 41.25 USD |
0
|
$2.42T 235.74B USD | $0 0 USD | $0 0 USD | $0 0 USD | $2.42T 235.74B USD | 0 | $0 0 USD | |
| Merck & Co., Inc. MRK.MX | $1,530 90.59 USD |
+0.39
|
$3.84T 227.49B USD | $207 12.26 USD | $1,514 89.65 USD | $1,530 90.59 USD | $3.84T 227.49B USD | 11.67 | $131.06 7.76 USD | |
| Merck & Co., Inc. MRCK34.SA | $55.42 11.23 USD |
+1.22
|
$1.11T 225.65B USD | $0 0 USD | $0 0 USD | $0 0 USD | $1.11T 225.65B USD | 11.74 | $4.72 0.96 USD | |
| AstraZeneca PLC AZNCF | $140.72 — |
-5.8
|
$218.15B — | $331 — | $140.72 — | $140.72 — | $218.15B — | 28.31 | $4.97 — | |
| Novartis AG NOTA.F | $98.4 107.56 USD |
0
|
$199.4B 217.97B USD | $1 1.09 USD | $98.4 107.56 USD | $98.4 107.56 USD | $199.4B 217.97B USD | 17.76 | $5.54 6.06 USD | |
| Amgen Inc. AMGN.BA | $10,775 12.74 USD |
-2.05
|
$177.46T 209.76B USD | $6.56K 7.76 USD | $10,650 12.59 USD | $11,375 13.45 USD | $177.46T 209.76B USD | 0.17 | $62.65K 74.06 USD | |
| AstraZeneca PLC ZEG.F | $122.35 133.75 USD |
-1.45
|
$189.67B 207.33B USD | $140 153.04 USD | $120 131.18 USD | $120 131.18 USD | $189.67B 207.33B USD | 28.32 | $4.32 4.72 USD | |
| AstraZeneca PLC ZEGA.F | $59.5 65.04 USD |
-4.03
|
$184.48B 201.66B USD | $5 5.47 USD | $59.5 65.04 USD | $59.5 65.04 USD | $184.48B 201.66B USD | 27.54 | $2.16 2.36 USD | |
| Merck & Co., Inc. MRK.SN | $79.09 — |
0
|
$198.6B — | $0 — | $79.09 — | $79.09 — | $198.6B — | 11.49 | $6.88 — | |
| Pfizer Inc. PFE.BA | $7,120 8.42 USD |
+1.57
|
$161.19T 190.53B USD | $12.55K 14.83 USD | $6,980 8.25 USD | $7,140 8.44 USD | $161.19T 190.53B USD | 2.25 | $3.15K 3.73 USD | |
| Merck & Co., Inc. MRK.VI | $68.6 74.99 USD |
-0.29
|
$172.47B 188.53B USD | $207 226.28 USD | $68.4 74.77 USD | $69.1 75.54 USD | $172.47B 188.53B USD | 11.47 | $5.98 6.54 USD | |
| Merck & Co., Inc. 6MK.DE | $68.4 74.77 USD |
-0.58
|
$171.75B 187.75B USD | $876 957.59 USD | $68.3 74.66 USD | $69.2 75.64 USD | $171.75B 187.75B USD | 11.43 | $5.98 6.54 USD | |
| Merck & Co., Inc. 6MK.F | $68.4 74.77 USD |
-0.87
|
$171.75B 187.75B USD | $371 405.55 USD | $68.4 74.77 USD | $69 75.43 USD | $171.75B 187.75B USD | 11.43 | $5.98 6.54 USD | |
| Gilead Sciences, Inc. GILD.BA | $31,450 37.17 USD |
-1.87
|
$154.23T 182.3B USD | $372 0.44 USD | $31,025 36.67 USD | $31,750 37.53 USD | $154.23T 182.3B USD | 5.78 | $5.44K 6.43 USD | |
| Amgen Inc. AMGN.MX | $5,511 326.32 USD |
0
|
$2.96T 175.46B USD | $0 0 USD | $5,511 326.32 USD | $5,511 326.32 USD | $2.96T 175.46B USD | 26.38 | $208.87 12.37 USD | |
| Amgen Inc. AMGN34.SA | $53.76 10.9 USD |
-4.73
|
$814.14B 165.01B USD | $0 0 USD | $0 0 USD | $0 0 USD | $814.14B 165.01B USD | 25.00 | $2.15 0.44 USD | |
| Amgen Inc. 0R0T.IL | $287.63 — |
+0.57
|
$157.63B — | $1 — | $0 — | $0 — | $157.63B — | 19.38 | $14.84 — | |
| Pfizer Inc. PFE.MX | $460 27.24 USD |
+0.02
|
$2.62T 154.86B USD | $207 12.26 USD | $456 27 USD | $460.29 27.25 USD | $2.62T 154.86B USD | 17.51 | $26.26 1.55 USD | |
| Gilead Sciences, Inc. GILD.MX | $2,100 124.35 USD |
0
|
$2.61T 154.68B USD | $4 0.24 USD | $2,100 124.35 USD | $2,100 124.35 USD | $2.61T 154.68B USD | 23.14 | $90.72 5.37 USD | |
| Pfizer Inc. PFIZ34.SA | $32.93 6.67 USD |
-0.75
|
$748.88B 151.79B USD | $0 0 USD | $0 0 USD | $0 0 USD | $748.88B 151.79B USD | 17.42 | $1.89 0.38 USD | |
| Gilead Sciences, Inc. GILD34.SA | $295.42 59.88 USD |
0
|
$741.37B 150.26B USD | $0 0 USD | $0 0 USD | $0 0 USD | $741.37B 150.26B USD | 22.56 | $13.09 2.65 USD | |
| Amgen Inc. AMGN.VI | $247.05 270.06 USD |
-2.35
|
$135.16B 147.74B USD | $37 40.45 USD | $250.65 273.99 USD | $252.7 276.24 USD | $135.16B 147.74B USD | 25.97 | $9.51 10.4 USD | |
| Amgen Inc. AMG.F | $249 272.19 USD |
-0.48
|
$134.51B 147.04B USD | $387 423.04 USD | $249 272.19 USD | $254.1 277.77 USD | $134.51B 147.04B USD | 26.12 | $9.53 10.42 USD | |
| Amgen Inc. AMG.DE | $247.2 270.22 USD |
-2.27
|
$132.92B 145.3B USD | $512 559.69 USD | $247.2 270.22 USD | $252.6 276.13 USD | $132.92B 145.3B USD | 25.91 | $9.54 10.43 USD | |
| Gilead Sciences, Inc. GILD.SN | $110.43 — |
0
|
$137.37B — | $0 — | $110.43 — | $110.43 — | $137.37B — | 23.19 | $4.76 — | |
| Pfizer Inc. PFE.SN | $23.8 — |
-8.67
|
$135.31B — | $0 — | $23.8 — | $23.8 — | $135.31B — | 17.24 | $1.38 — | |
| Bristol-Myers Squibb Company BMY.BA | $18,650 22.04 USD |
+2.05
|
$113.33T 133.96B USD | $612 0.72 USD | $18,175 21.48 USD | $18,650 22.04 USD | $113.33T 133.96B USD | 6.09 | $3.06K 3.62 USD | |
| Sanofi SANF.MI | $96.82 105.84 USD |
0
|
$121.24B 132.54B USD | $0 0 USD | $0 0 USD | $0 0 USD | $121.24B 132.54B USD | 0 | $0 0 USD | |
| Pfizer Inc. PFE.VI | $20.72 22.65 USD |
+0.12
|
$118.39B 129.42B USD | $621 678.84 USD | $20.82 22.75 USD | $20.93 22.88 USD | $118.39B 129.42B USD | 17.26 | $1.2 1.31 USD | |
| Gilead Sciences, Inc. GILD.VI | $91.76 100.31 USD |
-3.25
|
$117.25B 128.17B USD | $52 56.84 USD | $94.09 102.85 USD | $95.1 103.96 USD | $117.25B 128.17B USD | 22.21 | $4.13 4.51 USD | |
| Gilead Sciences, Inc. GIS.F | $92.57 101.19 USD |
-1.46
|
$115.54B 126.3B USD | $65 71.05 USD | $92.57 101.19 USD | $94.14 102.91 USD | $115.54B 126.3B USD | 22.41 | $4.13 4.51 USD | |
| Gilead Sciences, Inc. GIS.DE | $91.87 100.43 USD |
-2.99
|
$114.28B 124.92B USD | $803 877.79 USD | $91.87 100.43 USD | $95.12 103.98 USD | $114.28B 124.92B USD | 22.19 | $4.14 4.53 USD | |
| Pfizer Inc. PFEB.F | $6.7 7.32 USD |
-8.84
|
$112.17B 122.62B USD | $3 3.28 USD | $6.7 7.32 USD | $6.7 7.32 USD | $112.17B 122.62B USD | 16.34 | $0.41 0.45 USD | |
| Sanofi SNW.F | $83.8 91.6 USD |
+1.06
|
$102.28B 111.8B USD | $950 1.04K USD | $82.9 90.62 USD | $85 92.92 USD | $102.28B 111.8B USD | 16.79 | $4.99 5.45 USD | |
| Sanofi SANO.VI | $83.32 91.08 USD |
+0.39
|
$101.44B 110.89B USD | $95 103.85 USD | $83.04 90.77 USD | $83.7 91.5 USD | $101.44B 110.89B USD | 16.69 | $4.99 5.45 USD | |
| Sanofi SNW2.F | $41.2 45.04 USD |
0
|
$101.2B 110.63B USD | $10 10.93 USD | $41.2 45.04 USD | $41.2 45.04 USD | $101.2B 110.63B USD | 16.48 | $2.5 2.73 USD | |
| Bristol-Myers Squibb Company BMY.MX | $911 53.94 USD |
+2.42
|
$1.86T 110.11B USD | $11 0.65 USD | $889.5 52.67 USD | $889.5 52.67 USD | $1.86T 110.11B USD | 17.84 | $51.06 3.02 USD | |
| GSK plc GSK.BA | $11,325 13.39 USD |
0
|
$91.72T 108.41B USD | $118 0.14 USD | $11,150 13.18 USD | $11,400 13.48 USD | $91.72T 108.41B USD | 19.41 | $583.24 0.69 USD | |
| Bristol-Myers Squibb Company BMYB34.SA | $258.7 52.43 USD |
+0.41
|
$526.48B 106.71B USD | $0 0 USD | $0 0 USD | $0 0 USD | $526.48B 106.71B USD | 17.58 | $14.71 2.98 USD | |
| Gilead Sciences, Inc. GILD.MI | $72.4 79.14 USD |
0
|
$90.19B 98.59B USD | $0 0 USD | $0 0 USD | $0 0 USD | $90.19B 98.59B USD | 0 | $0 0 USD | |
| GSK plc GSKN.MX | $791 46.84 USD |
0
|
$1.6T 94.83B USD | $0 0 USD | $791 46.84 USD | $791 46.84 USD | $1.6T 94.83B USD | 20.24 | $39.08 2.31 USD | |
| Bristol-Myers Squibb Company BMYS.VI | $40.3 44.05 USD |
-1.38
|
$82.85B 90.56B USD | $0 0 USD | $40.7 44.49 USD | $41 44.82 USD | $82.85B 90.56B USD | 17.29 | $2.33 2.55 USD | |
| Bristol-Myers Squibb Company BRM.DE | $40.34 44.1 USD |
-1.3
|
$82.1B 89.74B USD | $1.17K 1.28K USD | $40.3 44.05 USD | $40.95 44.76 USD | $82.1B 89.74B USD | 17.31 | $2.33 2.55 USD | |
| Bristol-Myers Squibb Company BRM.F | $40.25 44 USD |
-1.32
|
$81.91B 89.54B USD | $300 327.94 USD | $40.25 44 USD | $41.15 44.98 USD | $81.91B 89.54B USD | 17.27 | $2.33 2.55 USD | |
| GSK plc G1SK34.SA | $41.96 8.5 USD |
0
|
$424.78B 86.1B USD | $0 0 USD | $0 0 USD | $0 0 USD | $424.78B 86.1B USD | 18.64 | $2.25 0.46 USD | |
| Chugai Pharmaceutical Co., Ltd. CUP.F | $44.28 48.4 USD |
+3.55
|
$73.27B 80.1B USD | $22 24.05 USD | $44.12 48.23 USD | $44.28 48.4 USD | $73.27B 80.1B USD | 29.71 | $1.49 1.63 USD | |
| Chugai Pharmaceutical CHGCF | $47.02 — |
-10.73
|
$77.38B — | $200 — | $52 — | $52 — | $77.38B — | 27.49 | $1.71 — | |
| Bayer Aktiengesellschaft BAY.MI | $55.5 60.67 USD |
0
|
$55.21B 60.36B USD | $0 0 USD | $0 0 USD | $0 0 USD | $55.21B 60.36B USD | 0 | $0 0 USD | |
| Daiichi Sankyo Company, Limited D4S.F | $19.24 21.03 USD |
-3.75
|
$35.84B 39.17B USD | $45 49.19 USD | $19.24 21.03 USD | $19.36 21.16 USD | $35.84B 39.17B USD | 20.68 | $0.93 1.02 USD | |
| Bayer Aktiengesellschaft BAYZF | $30.35 — |
-2.72
|
$29.82B — | $100 — | $30.35 — | $30.35 — | $29.82B — | 0 | -$3.83 — | |
| Bayer Aktiengesellschaft BAYER.BD | $10,900 30.15 USD |
0
|
$10.71T 29.62B USD | $41 0.11 USD | $10,900 30.15 USD | $10,900 30.15 USD | $10.71T 29.62B USD | 0 | -$1,336 -3.6 USD | |
| Bayer Aktiengesellschaft BAYN.VI | $26.35 28.8 USD |
-0.62
|
$26.22B 28.66B USD | $50 54.66 USD | $26.19 28.63 USD | $26.53 29 USD | $26.22B 28.66B USD | 0 | -$3.32 -3.6 USD | |
| Bayer Aktiengesellschaft BAYA.F | $6.4 7 USD |
-7.25
|
$25.15B 27.49B USD | $65 71.05 USD | $6.4 7 USD | $6.4 7 USD | $25.15B 27.49B USD | 0 | -$0.83 -0.9 USD | |
| Biogen Inc. BIIB.BA | $11,350 13.42 USD |
-0.22
|
$21.63T 25.57B USD | $938 1.11 USD | $11,175 13.21 USD | $11,500 13.59 USD | $21.63T 25.57B USD | 0.98 | $11.56K 13.66 USD | |
| Otsuka Holdings Co., Ltd. OS1.F | $41 44.82 USD |
-0.49
|
$22.03B 24.08B USD | $5 5.47 USD | $41 44.82 USD | $41 44.82 USD | $22.03B 24.08B USD | 10.53 | $3.89 4.25 USD | |
| Biogen Inc. BIIB34.SA | $124.32 25.2 USD |
0
|
$109.74B 22.24B USD | $0 0 USD | $0 0 USD | $0 0 USD | $109.74B 22.24B USD | 13.48 | $9.22 1.87 USD | |
| Biogen Inc. BIIB.MX | $2,550 150.99 USD |
0
|
$373.65B 22.12B USD | $0 0 USD | $2,550 150.99 USD | $2,550 150.99 USD | $373.65B 22.12B USD | 13.22 | $192.78 11.41 USD | |
| Astellas Pharma ALPMF | $10.1 — |
0
|
$18.08B — | $100 — | $10.1 — | $10.1 — | $18.08B — | 53.15 | $0.19 — | |
| Biogen Inc. IDP.F | $109.1 119.26 USD |
0
|
$16.17B 17.68B USD | $50 54.66 USD | $109.1 119.26 USD | $109.65 119.86 USD | $16.17B 17.68B USD | 12.41 | $8.79 9.61 USD | |
| Biogen Inc. BIIB.VI | $108.4 118.5 USD |
-1.45
|
$16.17B 17.68B USD | $0 0 USD | $110.15 120.41 USD | $110.95 121.28 USD | $16.17B 17.68B USD | 12.34 | $8.78 9.6 USD | |
| Biogen Inc. IDP.DE | $108.4 118.5 USD |
-1.54
|
$15.92B 17.41B USD | $1 1.09 USD | $108.4 118.5 USD | $110.95 121.28 USD | $15.92B 17.41B USD | 12.31 | $8.8 9.62 USD | |
| Astellas Pharma Inc. YPH.F | $8.18 8.94 USD |
-0.24
|
$14.64B 16.01B USD | $100 109.31 USD | $7.9 8.64 USD | $8.18 8.94 USD | $14.64B 16.01B USD | 48.11 | $0.17 0.19 USD | |
| Astellas Pharma Inc. YPHA.F | $7.7 8.42 USD |
-0.65
|
$14.38B 15.72B USD | $680 743.33 USD | $7.7 8.42 USD | $7.7 8.42 USD | $14.38B 15.72B USD | 45.29 | $0.17 0.19 USD | |
| Cipla Limited CIPLA.BO | $1,507.35 18.24 USD |
+0.6
|
$1.22T 14.75B USD | $503 6.09 USD | $1,503.6 18.19 USD | $1,510 18.27 USD | $1.22T 14.75B USD | 23.12 | $65.18 0.79 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.VI | $54.1 59.14 USD |
-0.18
|
$11.13B 12.17B USD | $0 0 USD | $53.8 58.81 USD | $54.15 59.19 USD | $11.13B 12.17B USD | 27.05 | $2 2.19 USD | |
| Recordati Industria Chimica e Farmaceutica S.p.A. RER1.F | $53.9 58.92 USD |
-0.37
|
$11.09B 12.12B USD | $40 43.73 USD | $53.55 58.54 USD | $53.9 58.92 USD | $11.09B 12.12B USD | 26.94 | $2 2.19 USD | |
| CSPC Pharmaceutical CHJTF | $1.05 — |
0
|
$11.99B — | $19.71K — | $1.05 — | $1.05 — | $11.99B — | 20.99 | $0.05 — | |
| CSPC Pharmaceutical CSPCY | $3.84 — |
-7.81
|
$11.22B — | $2.65K — | $3.85 — | $3.85 — | $11.22B — | 18.26 | $0.21 — | |
| CSPC Pharmaceutical Group Limited CVG.F | $0.8399 0.92 USD |
+2.89
|
$9.91B 10.83B USD | $4.25K 4.65K USD | $0.8399 0.92 USD | $0.8399 0.92 USD | $9.91B 10.83B USD | 20.98 | $0.04 0.04 USD | |
| CSPC Pharmaceutical Group Limited CVGU.F | $3.18 3.48 USD |
+2.58
|
$9.88B 10.8B USD | $4.35K 4.75K USD | $3.18 3.48 USD | $3.18 3.48 USD | $9.88B 10.8B USD | 17.66 | $0.18 0.2 USD | |
| Orion Oyj ORINY | $37.99 — |
+6.35
|
$10.46B — | $8 — | $37.99 — | $37.99 — | $10.46B — | 26.56 | $1.43 — | |
| Orion Oyj OFK0.F | $32 34.98 USD |
0
|
$8.96B 9.79B USD | $0 0 USD | $32 34.98 USD | $32 34.98 USD | $8.96B 9.79B USD | 25.80 | $1.24 1.36 USD | |
| Orion Oyj OFK.F | $63.8 69.74 USD |
-0.93
|
$8.87B 9.7B USD | $190 207.7 USD | $63.8 69.74 USD | $64.25 70.23 USD | $8.87B 9.7B USD | 25.72 | $2.48 2.71 USD | |
| Kyowa Kirin KYKOF | $17.14 — |
0
|
$8.97B — | $100 — | $15.8 — | $15.8 — | $8.97B — | 25.58 | $0.67 — | |
| Kyowa Kirin Co., Ltd. KY4.F | $14.5 15.85 USD |
-0.68
|
$7.72B 8.43B USD | $30 32.79 USD | $14.5 15.85 USD | $14.5 15.85 USD | $7.72B 8.43B USD | 25.00 | $0.58 0.63 USD | |
| Abbott India Limited ABBOTINDIA.NS | $31,200 377.47 USD |
+0.48
|
$673.21B 8.14B USD | $702 8.49 USD | $31,100 376.26 USD | $31,395 379.83 USD | $673.21B 8.14B USD | 46.95 | $664.47 8.04 USD | |
| Abbott India Limited ABBOTINDIA.BO | $31,195.05 377.41 USD |
+0.34
|
$672.26B 8.13B USD | $18 0.22 USD | $31,050 375.65 USD | $31,400 379.89 USD | $672.26B 8.13B USD | 46.88 | $665.3 8.05 USD | |
| Grifols GIFLF | $12.3 — |
+12.33
|
$7.69B — | $1.33K — | $10.95 — | $10.95 — | $7.69B — | 47.30 | $0.26 — | |
| Orion Oyj ORINF | $48.65 — |
0
|
$7.63B — | $43 — | $47.16 — | $47.16 — | $7.63B — | 19.69 | $2.47 — | |
|
좋아하는 주식 없음
아직 즐겨찾는 주식이 없습니다. 여기에서 보려면 즐겨찾기에 추가하세요. |
||||||||||
- {{ link.label }} {{link}}